This analysis involved data for responses to reduced NRAS-mRNA levels of more than one thousand cell lines, covering over 30 different cancer types (specifically CRISPR mediated loss-of-function data from 1150 cell lines and RNAi data from 710 cell lines). Here, NRAS is linked to cancer.